Search

Your search keyword '"Guyot, Erwan"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Guyot, Erwan" Remove constraint Author: "Guyot, Erwan"
37 results on '"Guyot, Erwan"'

Search Results

1. Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis

3. Supplementary Figure 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

4. Data from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

5. Supplementary Table 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

7. Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

10. Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

12. miR‐126‐3p is essential for CXCL12‐induced angiogenesis

13. Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study

14. Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells

15. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

18. Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis

19. A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

20. PS-047-HSD17B13 loss of function variant protects from hepatocellular carcinoma developed on alcohol related liver disease

21. Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.

22. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases

23. BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

24. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.

25. Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum

27. Determination of Heavy Metal Concentrations in Normal and Pathological Human Endometrial Biopsies and In Vitro Regulation of Gene Expression by Metals in the Ishikawa and Hec-1b Endometrial Cell Line

29. RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway

31. Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis

32. Association between thePNPLA3(rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

33. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data

34. Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis

36. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis

37. BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease.

Catalog

Books, media, physical & digital resources